European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Haleon UK Holdings Ltd., Weybridge

Watch
Haleon UK Holdings Ltd.

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Haleon UK Holdings Ltd.
Glaxosmithkline Consumer Healthcare Holdings Ltd.
Leo Constellation Ltd.

Identification

Chp
Companies House 08998608
Lei
549300QZEWI02JKJJW94

Address

The Heights, Building 5, First Floor, Weybridge KT13 0NY, United Kingdom
980 Great West Road Brentford Middlesex, United Kingdom

Corporate purpose

64.20/9
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Total assets

For this company, Total assets numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Taxes

For this company, Taxes numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
1Director
2Director
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Portfolio and Investments
2 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Receivables
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

23 Sept 2026 also 23/09/2025, 20/09/2021, 16/04/2018
Confirmation statement made with no updates
16 Sept 2026
Annual report for the year ending 31/12/2025
8 Apr 2026
No longer Director: Scott Ch. Bourgeois
2 Jan 2026
Director's details changed
26 Jun 2025
Annual report for the year ending 31/12/2024
26 Feb 2025
Resolution of adoption of Articles of Association (ADOPT ARTICLES) · Memorandum and Articles of Association
9 Oct 2024
Termination of appointment of Mariano Jesus Godino Escolar as a director
19 Sept 2024
Director: Khalid El Ansari
11 Sept 2024
Confirmation statement made with updates · Change of details for Haleon Intermediate Holdings Limited as a person with …
22 Aug 2024
Annual report for the year ending 31/12/2023
20 Oct 2023
Name: Haleon UK Holdings Ltd
2 Oct 2023
Annual report for the year ending 31/12/2022
14 Sept 2023 also 10/10/2022, 08/10/2020, 26/09/2019, 18/04/2019, 26/04/2017
Confirmation statement made with updates
15 May 2023
Director's details changed for Gsk Consumer Healthcare Holdings (No.8) Limited …
8 Feb 2023 also 16/12/2022, 29/07/2022, 27/05/2022, 26/05/2022, 11/09/2019, 05/06/2019, 11/06/2018
Companies House - Filing
15 Aug 2022
Director's details changed for Mr Scott Christopher Bourgeois
20 Jul 2022
No longer Director: Edinburgh Pharmaceutical Industries Ltd
19 Jul 2022
Director: Scott Ch. Bourgeois · No longer Director: Ciara M. Lynch, A. W. · No longer Director: The Wellcome Foundation Ltd. · No longer Secretary: Edinburgh Phamaceutical Industries Ltd. · Address
15 Jun 2022
Annual report for the year ending 31/12/2021
7 Jun 2022
Statement of capital following an allotment of shares · Memorandum and Articles of Association
31 May 2022
Statement of capital · Statement by Directors · Solvency Statement dated 30/05/22 …
24 May 2022
Appointment of Mr Mariano Jesus Godino Escolar as a director
31 Mar 2022
Particulars of variation of rights attached to shares · Change of share class name or designation
29 Mar 2022
Resolution of varying share rights or name · Resolution of adoption of Articles of Association (ADOPT ARTICLES)
24 Mar 2022
Memorandum and Articles of Association
2 Jul 2021
Annual report for the year ending 31/12/2020
via Ora in Ora
Partner: GlaxoSmithKline Manufacturing Slovakia a.s., Haleon Slovakia s.r.o. · No longer Partner: GlaxoSmithKline Manufacturing Slovakia a.s., Haleon Slovakia s.r.o.
11 Jun 2020
Annual report for the year ending 31/12/2019
23 Mar 2020
No longer Director: Tobias H. Hestler
18 Mar 2020
Director: Ciara Martha Lynch
5 Sept 2019
Director: Adam Walker · No longer Director: Brian James Mcnamara, David Simon Redfern
4 Sept 2019
Director: Edinburgh Pharmaceutical Industries Ltd., The Wellcome Foundation Ltd
10 Jun 2019
Statement of capital following an allotment of shares · Change of share class name or designation …
13 May 2019
No longer Director: Simon Paul Dingemans
11 Apr 2019
Annual report for the year ending 31/12/2018
10 Apr 2019
Appointment of Mr Iain James Mackay as a director
13 Jun 2018
No longer Director (3)
1 Jun 2018
No longer Director (4)
25 May 2018
Statement of capital
23 May 2018
Capital: £100,000
22 May 2018
Capital: £100,000
18 Apr 2018
Annual report for the year ending 31/12/2017
13 Oct 2017
No longer Director: Jonathan Wilson Box
5 Oct 2017
Director: Tobias H. Hestler
7 Jul 2017
No longer Director: Andrew Philip Witty
4 Jul 2017
Director: Augusto Lima
19 Jun 2017
Termination of appointment of Marvelle Elizabeth Sullivan Berchtold as a director
22 Apr 2017
Director: Roger Connor
10 Apr 2017
Annual report for the year ending 31/12/2016
19 Oct 2016
Director: John Richard Slater
22 Sept 2016 also 17/06/2015
Full accounts made up to 2015-12-31
21 Sept 2016
No longer Director (1)
16 Mar 2016
Statement by Directors · Solvency Statement dated 10/03/16 · The share premium account be reduced. 10/03/2016
9 Jan 2016
Second filing of SH01 previously delivered to Companies House · Statement of capital following an allotment of shares
31 Dec 2015 also 04/03/2015
Statement of capital following an allotment of shares
20 May 2015
Change of share class name or designation
24 Apr 2015
Director: Susanne Schaffert
23 Apr 2015
Secretary: Edinburgh Phamaceutical Industries Ltd
13 Apr 2015
Statement of capital following an allotment of shares · Clarification this was a duplicate front page to the …
27 Mar 2015
Director: Steven Baert
22 Mar 2015 via Haleon Denmark ApS
Shareholding, No longer Voting rights: Glaxosmithkline Consumer Healthcare A/S
20 Mar 2015
Resolution of adoption of Articles of Association (ADOPT ARTICLES)
13 Mar 2015
Director: Andrew Philip Witty
10 Mar 2015
No longer Director (2) · No longer Director: Edinburgh Pharmaceutical Industries Ltd
9 Mar 2015
Director (7)
20 Feb 2015 via Haleon Denmark ApS
Shareholding, Voting rights: Glaxosmithkline Consumer Healthcare A/S
18 Dec 2014
Current accounting period shortened from 2015-04-30 to 2014-12-31
2 Oct 2014
Name: Glaxosmithkline Consumer Healthcare Holdings Ltd
15 Apr 2014
Reg­is­tra­tion: 15/04/2014 · Director (2) · Director: Edinburgh Pharmaceutical Industries Ltd
There are no publications matching your search.

Mentions

26 Oct 2026 in Ler
Direct parent
26 Oct 2026 in Ler
Ultimate parent
7 Apr 2026 in Or
Partner: GlaxoSmithKline Manufacturing Slovakia a.s
via Companies House in Psc
BO: Haleon UK Holdings (NO.3) Ltd., Stafford-Miller Ltd., Haleon UK Holdings (NO.2) Ltd. · VR: Haleon UK Holdings (NO.3) Ltd., Haleon UK Holdings (NO.2) Ltd. …
28 Dec 2023 in Ler
No longer Ultimate parent
in Ler
No longer Direct parent: Glaxosmithkline Consumer Healthcare (Overseas) Ltd. · Direct parent (4 companies)
22 Dec 2023 in Ler
No longer Direct parent
6 Apr 2021 in Ler
No longer Ultimate parent: Haleon UK Finance Ltd
28 Oct 2020 in Ler
No longer Ultimate parent: GSK Consumer Healthcare SA AG
in Ler
Direct parent (4 companies)
7 Apr 2015 in Wzfma also 02/04/2015, 31/03/2015, 27/03/2015
Shareholding: GlaxoSmithKline Consumer Healthcare GmbH
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.